Post by
Ciao on Aug 20, 2024 9:58am
Q2 earnings Q&A
On track for $28 to $32M rev in 2024. $10M plus Q4 expected. 2025 rev target of $40M. None of these revenues take into account potential of new sales once EPA approval is received from leach studies for their kill claim on apparel.
Comment by
Daudau11 on Aug 28, 2024 3:38pm
Hey Ciao, I already own IFA too. Its either this famous saying, "Great minds think alike." or "Idiots love company." LOL
Comment by
Daudau11 on Aug 28, 2024 3:41pm
I think just like IFX, IFA has improving financials and again game changing potential when they get EPA kill claim. Its just a matter of time. Both requires patience.
Comment by
Ciao on Aug 28, 2024 3:45pm
IFA has targeted 25% plus rev growth in 2024. Any appararel sales is gravy for them. Yes, patience is needed once again, and for those who need to own more shares, there is more time to do so.
Comment by
Ciao on Aug 28, 2024 3:54pm
forgot to add: any "kill claim related" apparel sales is gravy for them
Comment by
Daudau11 on Aug 28, 2024 5:12pm
yea they have and the mkt doesn't seem to care
Comment by
Ciao on Aug 28, 2024 5:47pm
It just doesn't have the visibility that others have right now. If you follow the WOLF, he thinks the share price reflects the potential of EPA approval, which I wholeheartedly disagree with. Should the next pandemic come, we are hedged :-)
Comment by
Daudau11 on Aug 29, 2024 8:54am
well we already have Mpox spreading around
Comment by
Ciao on Aug 29, 2024 11:33am
Avian flu is on the horizon. https://www.aljazeera.com/opinions/2024/7/21/has-the-next-pandemic-already-started The stock had a nice spike during COVID that allowed them to raise some capital. Any thoughts on Canacord being a buyer while there is ANON selling pressure?
Comment by
Daudau11 on Aug 29, 2024 4:26pm
Nope, have no idea who at Canaccord is buying but today's volume was all bought up by them. Anon. only sold in the morning and that was it. Most of the bigger volume trades happened around 1pm and Anon. was no where to be seen.
Comment by
Method on Aug 28, 2024 10:57pm
There is no analyst coverage so nothing to cya institutional investors or forward estimates for quants. That being said, if Q4 really is $10m+ as they are suggesting then profitability should increase significantly which will show up on screens as there shoild be significant operating leverage.
Comment by
Ciao on Aug 28, 2024 11:09pm
There's no need to raise capital at this time, so no underwriting fees for anyone. The founder of Catalyst Equity Research issues regular reports on IFA. https://catalystresearch.ca/about.html